Asthma and the unified airway

Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 5 SUPPL., 2007, Pages

  Krouse, John H ^a   Brown, Randall W ^b   Fineman, Stanley M ^c   Han, Joseph K ^d   Heller, Andrew J ^e   Joe, Stephanie ^f   Krouse, Helene J ^a   Pillsbury III, Harold C ^g   Ryan, Matthew W ^h   Veling, Maria C ⁱ  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Atlanta Allergy and Asthma Clinic   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

ⁱ UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CYCLOOXYGENASE 1 INHIBITOR; FLUTICASONE PROPIONATE; GLUCOCORTICOID; IMMUNOGLOBULIN E ANTIBODY; IMMUNOMODULATING AGENT; METHYLPREDNISOLONE ACETATE; MOMETASONE FUROATE; MONTELUKAST; PRANLUKAST; PREDNISONE; PROSTAGLANDIN; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST; ZILEUTON;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; COMORBIDITY; CONJUNCTIVA DISEASE; CONTROLLED CLINICAL TRIAL; DEATH; DRUG MECHANISM; DRUG MEGADOSE; DRUG SENSITIVITY; DYSPHONIA; ENDOSCOPY; FLUSHING; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; LOW DRUG DOSE; LUNG FUNCTION TEST; MONOTHERAPY; NOSE SURGERY; ORBIT EDEMA; OROPHARYNX CANDIDIASIS; PATHOPHYSIOLOGY; PHYSICIAN; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; RHINORRHEA; RHINOSINUSITIS; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; SMOKING; TACHYPHYLAXIS;

ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; PATIENT CARE TEAM; QUALITY OF LIFE; RESPIRATORY TRACT DISEASES; RHINITIS; RISK FACTORS; SINUSITIS;

EID: 34247279632     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2007.02.019     Document Type: Article

References (156)

1. Pillsbury III H.C., Krouse J.H., Marple B.F., et al. The impact/role of asthma in otolaryngology. Otolaryngol Head Neck Surg 136 1 (2007) 157
2. Passalacqua G., Ciprandi G., and Canonica G.W. United airways diseases: therapeutic aspects. Thorax 55 (2000) S26-S27
3. Bousquet J., van Cauwenberge P., Khaltaev, et al. Allergic rhinitis and its impact on asthma (ARIA): executive summary of the workshop report. Allergy 57 (2002) 841-855
4. Corren J. Allergic rhinitis and asthma: how important is the link?. J Allergy Clin Immunol 99 (1997) S781-S786
5. Guerra S., Sherrill D.L., Martinez F.D., et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 109 (2002) 419-425
6. Settipane R.J., Hagy G.Y., and Settipane G.A. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up of college students. Allergy Proc 15 (1994) 21-25
7. Huse D.M., Harte S.C., Russel M.W., et al. Allergic rhinitis may worsen asthma symptoms in children: the International Asthma Outcomes registry. Am J Resp Crit Care Med 153 (1996) A860
8. Linneberg A., Henrik Nielsen L., Frolund F., et al. The link between allergic rhinitis and asthma: a prospective, population-based study, the Copenhagen Allergy Study. Allergy 57 (2002) 1048-1052
9. Shturman-Ellstein R., Zeballos R.J., Buckley J.M., et al. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis 118 (1978) 877-884
10. Braunstahl G.J., Kleinjan A., Overbeek S.E., et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 161 (2000) 2051-2057
11. Braunstahl G.J., Overbeek S.E., Kleinjan A., et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 107 (2001) 469-476
12. Braunstahl G.J., Overbeek S.E., Fokkens W.J., et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 164 (2001) 858-865
13. Braunstahl G.J., and Hellings P.W. Allergic rhinitis and asthma: the link further unraveled. Curr Opin Pulm Med 9 (2003) 46-51
14. Madonini E., Briatico-Vangosa G., Pappacoda A., et al. Seasonal increase in bronchial reactivity in allergic rhinitis. J Allergy Clin Immunol 79 (1987) 358-363
15. Corren J., Adinoff A.D., and Irvin C.G. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 89 (1992) 611-618
16. Stelmach R., do Patrocinio T., Nunes M., et al. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to moderate persistent asthma. Chest 128 (2005) 3140-3147
17. Watson W.T., Becker A.B., and Simons F.E. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 91 (1993) 97-101
18. Fuhlbrigge A.L., and Adams R.J. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr Opin Allergy Clin Immunol 3 (2003) 29-32
19. Yawn B.P., Yunginger J.W., Wollan P.C., et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 103 (1999) 54-59
20. Thomas M., Kocevar V.S., Zhang Q., et al. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics 115 (2005) 129-134
21. Stelmach R., Nunes M.D.P., Ribeiro M., et al. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 128 (2005) 3140-3147
22. Möller C., Dreborg S., Ferdousi H.A., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol 109 (2002) 251-256
23. Johnstone D.E., and Dutton A. The value of hyposensitization therapy for bronchial asthma in children-a 14 year study. Pediatrics 42 (1968) 793-802
24. Jacobsen L., Nuchel P.B., Wihl H.A., et al. Immunotherapy with partially purified and standardized tree pollen extracts. IV: results from long-term (6 year) follow-up. Allergy 52 (1997) 914-920
25. Meltzer E.O. The relationships of rhinitis and asthma. Allergy Asthma Proc 26 (2005) 336-340
26. Prieto J., Gutierrez V., Berto J.M., et al. Sensitivity and maximal response to methacholine in perennial and seasonal allergic rhinitis. Clin Exp Allergy 26 (1996) 61-67
27. Greisner W.A., Settipane R.J., and Settipane G.A. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 19 (1998) 185-188
28. Huovinen E., Kaprio J., Laitinen L.A., et al. Incidence and prevalence of asthma among adult Finnish men and women of the Finnish twin cohort from 1975 to 1990, and their relation to hay fever and chronic bronchitis. Chest 115 (1999) 928-936
29. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 111 (2003) 1171-1183
30. Leynaert B., Bousquet J., Neukirch C., et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. J Allergy Clin Immunol 104 (1999) 301-304
31. Leynaert B., Bousquet J., Henry C., et al. Is bronchial hyperresponsiveness more frequent in women than men?. Am J Respir Crit Care Med 156 (1997) 1413-1420
32. Kocevar V.S., Bisgaard H., Jonsson L., et al. Variations in pediatric asthma hospitalization rates and costs between and within Nordic countries. Chest 125 (2004) 1680-1684
33. Halpern M.T., Schmier J.K., Richner R., et al. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. J Asthma 41 1 (2004) 117-126
34. Fontanari P., Burnet H., Zatarra-Hartmann M.C., et al. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol 81 4 (1996) 1739-1743
35. American Thoracic Society Workshop. Immunobiology of asthma and rhinitis: pathogenic factors and therapeutic options. Am J Respir Crit Care Med 160 (1999) 1778-1787
36. Meltzer E.O. Role for cysteinyl leukotrienes receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one airway linked disease.". Ann Allergy Asthma Immunol 84 (2000) 176-187
37. Pawankar R. Allergic rhinitis and asthma: are they manifestations of one syndrome?. Clin Exp Allergy 36 (2006) 1-4
38. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J 20 (2002) 1071-1079
39. Taramarcaz P., and Gibson P.G. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database of Systematic Reviews (2003) Issue 3. Art. No.:CD003570.DOI: 10.1002/14651858.CD003570.
40. Thio B.J., Slingerland G.L.M., Fredriks A.M., et al. Influence of intranasal steroids during the grass pollen season on bronchial responsiveness in children and young adults with asthma and hay fever. Thorax 55 (2000) 826-832
41. Lanza D.C., and Kennedy D.W. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117 (1997) S1-S7
42. Benninger M.S., Ferguson B.J., Hadley J.A., et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology and pathophysiology. Otolaryngol Head Neck Surg 129 3 Suppl (2003) S1-S32
43. Meltzer E.O., Hamilos D.L., Hadley J.A., et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 131 (2004) S1-S62
44. Jani A., and Hamilos D. Current thinking on the relationship between rhinosinusitis and asthma. J Asthma 42 (2005) 1-7
45. Hamilos D. Chronic sinusitis. J Allergy Clin Immunol 106 (2000) 213-227
46. Demoly P., Crampette L., Mondain M., et al. Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol 84 1 (1994) 95-108
47. Tedeschi A., Palumbo G., Milazzo N., et al. Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor. J Allergy Clin Immunol 93 (1994) 526-533
48. Bachert C., Vignola M., Gevaert P., et al. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin N Am 24 (2004) 19-43
49. Annesi-Maesano I. Epidemiological evidence of the occurrence of rhinitis and sinusitis in asthmatics. Allergy 54 (1999) 7-13
50. Scadding G. The effect of medical treatment of sinusitis upon concomitant asthma. Allergy 57 (1999) 136-140
51. Senior B., Kennedy D., and Tanabodee J. Long-term impact of functional endoscopic sinus surgery on asthma. Otolaryngol Head Neck Surg 121 (1999) 66-68
52. Dhong H., Hyo K., and Cho D. Histopathologic characteristics of chronic sinusitis with bronchial asthma. Acta Oto-Laryngologica 125 (2005) 169-176
53. Harlin S., Ansel D., Lane S., et al. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 81 (1988) 867-875
54. Ponikau J., Sherris D., Kephart G., et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma?. J Allergy Clin Immunol 112 (2003) 877-882
55. Barrios R., Kheradmand F., Batts L., et al. Asthma: pathology and pathophysiology. Arch Pathol Lab Med 130 (2006) 447-451
56. Lemanske R.F., and Busse W.W. Asthma. J Allergy Clin Immunol 111 (2003) S502-S519
57. Denburg J. The nose, the lung and the bone marrow in allergic inflammation. Allergy 57 (1999) 73-80
58. Bresciani M., Paradis L., Des Roches A., et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 107 (2001) 73-80
59. ten Brinke A., Grootendorst D., and Schmidt J. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 109 (2002) 621-626
60. Batra P., Kern R., Tripathi A., et al. Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma. Laryngoscope 113 (2003) 1703-1706
61. Slavin R. Asthma and sinusitis. J Allergy Clin Immunol 90 3 Pt 2 (1992) 534-537
62. Jankowski R., Moneret-Vautrin D.A., Goets R., et al. Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma. Rhinology 30 (1992) 249-258
63. Alobid I., Benitez P., Bernal-Sprekelsen M., et al. The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res 14 (2005) 789-793
64. Lund V. The effect of sinonasal surgery on asthma. Allergy 57 (1999) 141-145
65. Rachelefsky G., Katz R., and Siegel S. Chronic sinus disease with associated reactive airway disease in children. Pediatrics 73 (1984) 526-529
66. Pfaar O., and Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol 6 (2006) 161-166
67. Szczeklik A., and Stevenson D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111 (2003) 913-921
68. Gosepath J., Schaefer D., Amedee R.G., et al. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 127 (2001) 316-321
69. Sousa A., Parikh A., Scadding G., et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Eng J Med 347 (2002) 1493-1499
70. Nakamura H., Kawasaki M., Higuchi Y., et al. Effects of sinus surgery on asthma in aspirin triad patients. Acta Otolaryngol (Stockh) 119 (1999) 592-598
71. Parikh A.A., and Scadding G.K. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 115 (2005) 1385-1390
72. Meltzer E.O., Szwarcberg J., and Pill M.W. Allergic rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway. J Manag Care Pharm 10 (2004) 310-317
73. Bush R.K. The use of anti-IgE in the treatment of allergic asthma. Med Clin N Am 86 (2002) 1113-1129
74. Jones C., and Holt P. Immunopathology of allergy and asthma in childhood. Am J Respir Crit Care Med 162 (2000) S36-S39
75. Bousquet J., Van Cauwenberge P., Khaltaev N., and ARIA Workshop Group. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 Suppl 5 (2001) S147-S334
76. Ramsdale E.H., Morris M.M., Roberts R.S., et al. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol 75 (1985) 573-577
77. Braman S.S., Barrows A.A., Decons H.A., et al. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 91 (1987) 671-674
78. Dinakar C., and Portnoy J.M. Allergen immunotherapy in the prevention of asthma. Curr Opin Allergy Clin Immunol 4 (2004) 131-136
79. Murray J.J., and Rusznak C. Asthma and rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 11 (2003) 49-53
80. Prescott S.L., Macaubas C., Holt B.J., et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 160 (1998) 4730-4737
81. Holt P.G., Macaubas C., Stumbles P.A., et al. The role of allergy in the development of asthma. Nature 402 (1999) B12-B17
82. Holt P.G., and Macaubas C. Development of long-term tolerance versus sensitization to environmental allergens during the perinatal period. Curr Opin Immunol 9 (1997) 782-787
83. Ball T.M., Castro-Rodriguez J.A., Griffin K.A., et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 343 (2000) 538-543
84. Prescott S.L., Macaubas C., Smallacombe T., et al. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353 9148 (1999) 196-200
85. Tang E., Wiesch D., and Samet J. Epidemiology of asthma and allergic disease. In: Adkinson Jr. N.F., Yunginger J.W., and Busse W.W. (Eds). Middleton's allergy: principles and practice. 6th ed. (2003), Mosby, Philadelphia 1127-1144
86. Centers for Disease Control and Prevention. Measuring childhood asthma prevalence before and after the 1997 redesign of the National Health Interview Survey: United States. MMWR Morb Mortal Wkly Rep 49 (2000) 908-911
87. Mannino D.M., Homa D.M., Akinbami L.J., et al. Surveillance for asthma: United States, 1980-1999. MMWR Surveill Summ 51 1 (2002) 1-13
88. Taussig L.M. Maximal expiratory flows at functional residual capacity: a test of lung function for young children. Am Rev Respir Dis 116 6 (1977) 1031-1038
89. National Center for Health Statistics. National Health Interview Survey (2006). http://www.cdc.gov/nchs/data/nhis/earlyrelease/200606_15.pdf Available from: URL: www.cdc.gov/nchs/data/nhis/earlyrelease/200606_15.pdf.
90. Centers for Disease Control. Asthma prevalence: health care use and mortality (2002). http://www.cdc.gov/nchs/data/asthmahealthestat1.pdf Available from: URL: http://www.cdc.gov/nchs/data/asthmahealthestat1.pdf.
91. Smith L.A., Hatcher-Ross J.L., Wertheimer R., et al. Rethinking race/ethnicity, income, and childhood asthma: racial/ethnic disparities concentrated among the very poor. Public Health Rep 120 2 (2005) 109-116
92. Simon P.A., Zeng Z., Wold C.M., et al. Prevalence of childhood asthma and associated morbidity in Los Angeles County: impacts of race/ethnicity and income. J Asthma 40 5 (2003) 535-543
93. Nicholas S.W., Jean-Louis B., Ortiz B., et al. Addressing the childhood asthma crisis in Harlem: the Harlem Children's Zone Asthma Initiative. Am J Public Health 95 2 (2005) 245-249
94. Strachan D.P., and Cook D.G. Health effects of passive smoking. 6. parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 53 3 (1998) 204-212
95. Eisner M.D., Yelin E.H., Henke J., et al. Environmental tobacco smoke and adult asthma: the impact of changing exposure status on health outcomes. Am J Respir Crit Care Med 158 1 (1998) 170-175
96. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 23 (2004) 2847-2850
97. Ford E.S. The epidemiology of obesity and asthma. J Allergy Clin Immunol 115 5 (2005) 897-909
98. Weiss S.T., and Shore S. Obesity and asthma: directions for research. Am J Respir Crit Care Med 169 8 (2004) 963-968
99. Marbury M.C., Maldonado G., and Waller L. Lower respiratory illness, recurrent wheezing, and day care attendance. Am J Respir Crit Care Med 155 1 (1997) 156-161
100. Castro-Rodriguez J.A., Holberg C.J., Wright A.L., et al. Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med 159 6 (1999) 1891-1897
101. Martinez F.D., Morgan W.J., Wright A.L., et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 319 17 (1988) 1112-1117
102. Centers for Disease Control and Prevention. Surveillance for asthma: United States, 1980-1999. MMWR Surveill Summ 51 (2002) 1-13
103. Beasley R. The burden of asthma with specific reference to the United States. J Allergy Clin Immunol 109 5 Suppl (2002) S482-S489
104. Weiss K.B., Sullivan S.D., and Lyttle C.S. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 106 3 (2000) 493-499
105. Sly R.M. Continuing decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol 92 3 (2004) 313-318
106. Rees J. ABC of asthma: definition and diagnosis. Br Med J (Clin Res Ed) 288 (1984) 1370-1372
107. National Asthma Education and Prevention Program (NAEPP). Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 88 (1991) 425-534
108. National Heart, Lung, and Blood Institute. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma (1997), NIH, Bethesda, MD National Institutes of Health pub no. 97-4051.
109. National Heart, Lung, and Blood Institute. Global initiative for asthma: global strategy for asthma management and prevention. NHLBI/WHO Workshop Report (1995), NIH, Bethesda, MD National Institutes of Health pub no. 95-3659.
110. Busse W.W., and Lemanske Jr. R.F. Asthma. N Engl J Med 344 (2001) 350-362
111. Laitinen A., Altraja A., Kampe M., et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 156 (1997) 951-958
112. van den Toorn L.M., Overbeek S.E., de Jongste J.C., et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 164 (2001) 2107-2113
113. Sunyer J., Anto J.M., Sabria J., et al. Relationship between serum IgE and airway responsiveness in adults with asthma. J Allergy Clin Immunol 95 (1995) 699-706
114. Louis R., Lau L.C., Bron A.O., et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161 (2000) 9-16
115. Pavord I.D., Ward R., Woltmann G., et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 160 (1999) 1905-1909
116. Braun-Fahrlander C., Riedler J., Herz U., et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347 (2002) 869-877
117. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. update on selected topics 2002 (2002), NIH, Bethesda, MD National Institutes of Health pub no. 02-5075.
118. Pellegrino R., Viegi G., Brusasco R.O., et al. Interpretative strategies for lung function testing. Eur Respir J 26 (2005) 948-968
119. Ingram R.H. Lung function assessment and thoracic diagnostic techniques. Resp 14 (2003) 2-17
120. Nathan R.A., Sorkness C.A., Kosinski M., et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
121. Juniper E.F., O'Byrne P.M., Guyatt G.H., et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 14 (1999) 902-907
122. Global Initiative for Asthma. Pocket guide for asthma management and prevention (2004). http://www.ginasthma.com (Retrieved 8/9/06 from http://www.ginasthma.com)
123. Bateman E.D., Frith L.F., and Braunstein G.L. Achieving guideline-based asthma control: does the patient benefit?. Eur Respir J 20 (2002) 588-595
124. Jarjour N.N., and Kelly E.A. Pathogenesis of asthma. Med Clin North Am 86 (2002) 925-936
125. Rabe K.F., Vermeire P.A., Soriano J.B., et al. Clinical management of asthma in 1999: the asthma insights and in reality in Europe (AIRE) study. Eur Respir J 16 (2000) 802-807
126. Rushford N., Tiller J.W.G., and Pain M.C.F. Perception of natural fluctuations in peak flow in asthma: clinical severity and psychological correlates. J Asthma 35 (1998) 251-259
127. Kendrick A.H., Higgs C.M.B., Whitfield M.J., et al. Accuracy of perception of severity of asthma: patients treated in general practice. Br Med J 307 (1993) 422-424
128. Katz P.P., Yelin E.H., Eisner M.D., et al. Perceived control of asthma and quality of life among adults with asthma. Ann Allergy Asthma Immunol 89 (2002) 251-258
129. Combescure C., Chanez P., Saint-Pierre P., et al. Assessment of variations in control of asthma over time. Eur Respir J 22 (2003) 298-304
130. Vollmer W.M. Assessment of asthma control and severity. Ann Allergy Asthma Immunol 93 (2004) 409-414
131. Vollmer W.M., Markson L.E., O'Connor E., et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 160 (1999) 1647-1652
132. Vollmer W.M., Markson L.E., O'Connor E., et al. Association of asthma control with health care utilization. Am J Respir Crit Care Med 165 (2002) 195-199
133. Juniper E.F., O'Byrne P.M., Ferrie P.J., et al. Measuring asthma control: clinic questionnaire or daily diary?. Am J Respir Crit Care Med 162 (2000) 1330-1334
134. Boulet L.P., Phillips R., O'Byrne P.M., et al. Evaluation of asthma control by physicians and patients: comparison with current guidelines. Can Respir J 9 (2002) 417-423
135. Boulet L.P., Boulet V., and Milot J. How should we quantify asthma control?. Chest 122 (2002) 2217-2223
136. Global initiative for asthma: global strategy for asthma management and prevention 2006. Available at: www.ginasthma.org. Accessed 12/4/06.
137. Gilliland F.D., Berhane K., McConnell R., et al. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax 55 (2000) 271-276
138. Byrd R.S., and Joad J.P. Urban asthma. Curr Opin Pulm Med 12 (2006) 68-74
139. Patterson P.E., and Harding S.M. Gastroesophageal reflux disorders and asthma. Curr Opin Pulm Med 5 (1999) 63-67
140. Self T., Soberman J.E., Bubla J.M., et al. Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks. J Asthma 40 (2003) 839-845
141. Beuther D.A., Weiss S.T., and Sutherland E.R. Obesity and asthma. Am J Crit Care Med 174 (2006) 112-119
142. Wright R.J. Stress and atopic disorders. J Allergy Clin Immunol 116 (2005) 1301-1306
143. Nelson H.S., Weiss S.T., Bleecker E.R., et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
144. Randell T.L., Donaghue K.C., Ambler G.R., et al. Safety of the newer inhaled corticosteroids in childhood asthma. Paediatr Drugs 5 (2003) 481-504
145. White M., Crisalida T., Li H., et al. Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma. Ann Allergy Asthma Immunol 96 (2006) 437-444
146. Pedersen S. Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf 29 (2006) 599-612
147. Sharek P.J., and Bergman D.A. The effects of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 106 (2000) E8
148. Sorkness C.A. Leukotriene receptor antagonists in the treatment of asthma. Pharmacotherapy 21 (2001) S34-S37
149. Ducharme F.M., Schwartz Z., Hicks G., et al. Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2 (2004) CD003133.
150. Ducharme F.M. Inhaled corticosteroids versus leukotriene antagonists as first-line therapy for asthma: a systematic review of current evidence. Treat Respir Med 3 (2004) 399-405
151. Ducharme F.M., Lasserson T.J., and Cates C.J. Long-acting beta 2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 4 (2006) CD003137.
152. Ni Chroinin M., Greenstone I.R., Danish A., et al. Long-acting beta 2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev 4 (2005) CD005535.
153. Haney S., and Hancox R.J. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 31 (2006) 181-196
154. Abramson M.J., Walters J., and Walters E.H. Adverse effects of beta-agonists: are they clinically relevant?. Am J Respir Med 2 (2003) 287-297
155. Hansel T.T., Tennant R.C., Tan A.J., et al. Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease. Drugs Today (Barc) 40 (2004) 55-69
156. Bennett J.A., Thompson Coon J., Pavord I.D., et al. The airway effects of stopping regular oral theophylline in patients with asthma. Br J Clin Pharmacol 45 (1998) 402-404